Literature DB >> 16648375

Mutational spectrum of COH1 and clinical heterogeneity in Cohen syndrome.

W Seifert, M Holder-Espinasse, S Spranger, M Hoeltzenbein, E Rossier, H Dollfus, D Lacombe, A Verloes, K H Chrzanowska, G H B Maegawa, D Chitayat, D Kotzot, D Huhle, P Meinecke, B Albrecht, I Mathijssen, B Leheup, K Raile, H C Hennies, D Horn.   

Abstract

Cohen syndrome (CS) is an autosomal recessive disorder with variability in the clinical manifestations, characterised by mental retardation, postnatal microcephaly, facial dysmorphism, pigmentary retinopathy, myopia, and intermittent neutropenia. Mutations in the gene COH1 have been found in an ethnically diverse series of patients. Brief clinical descriptions of 24 patients with CS are provided. The patients were from 16 families of different ethnic backgrounds and between 2.5 and 60 years of age at assessment. DNA samples from all patients were analysed for mutations in COH1 by direct sequencing. Splice site mutations were characterised using reverse transcriptase PCR analysis from total RNA samples. In this series, we detected 25 different COH1 mutations; 19 of these were novel, including 9 nonsense mutations, 8 frameshift mutations, 4 verified splice site mutations, 3 larger in frame deletions, and 1 missense mutation. We observed marked variability of developmental and growth parameters. The typical facial gestalt was seen in 23/24 patients. Early onset progressive myopia was present in all the patients older than 5 years. Widespread pigmentary retinopathy was found in 12/14 patients assessed over 5 years of age. We present evidence for extended allelic heterogeneity of CS, with the vast majority of mutations leading to premature termination codons in COH1. Our data confirm the broad clinical spectrum of CS with some patients lacking even the characteristic facial gestalt and pigmentary retinopathy at school age.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648375      PMCID: PMC2564527          DOI: 10.1136/jmg.2005.039867

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

Review 1.  Cohen syndrome: evaluation of its cardiac, endocrine and radiological features.

Authors:  S Kivitie-Kallio; M Eronen; M Lipsanen-Nyman; E Marttinen; R Norio
Journal:  Clin Genet       Date:  1999-07       Impact factor: 4.438

2.  Allelic heterogeneity in the COH1 gene explains clinical variability in Cohen syndrome.

Authors:  Hans Christian Hennies; Anita Rauch; Wenke Seifert; Christian Schumi; Elisabeth Moser; Eva Al-Taji; Gholamali Tariverdian; Krystyna H Chrzanowska; Malgorzata Krajewska-Walasek; Anna Rajab; Roberto Giugliani; Thomas E Neumann; Katja M Eckl; Mohsen Karbasiyan; André Reis; Denise Horn
Journal:  Am J Hum Genet       Date:  2004-05-20       Impact factor: 11.025

3.  COH1 analysis and linkage study in two Japanese families with Cohen syndrome.

Authors:  I Kondo; A Shimizu; S Asakawa; K Miyamoto; H Yamagata; Y Tabara; N Shimizu
Journal:  Clin Genet       Date:  2005-03       Impact factor: 4.438

4.  A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies.

Authors:  M M Cohen; B D Hall; D W Smith; C B Graham; K J Lampert
Journal:  J Pediatr       Date:  1973-08       Impact factor: 4.406

5.  Allele-specific suppression of a defective trans-Golgi network (TGN) localization signal in Kex2p identifies three genes involved in localization of TGN transmembrane proteins.

Authors:  K Redding; J H Brickner; L G Marschall; J W Nichols; R S Fuller
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Analysis of the human VPS13 gene family.

Authors:  Antonio Velayos-Baeza; Andrea Vettori; Richard R Copley; Carol Dobson-Stone; A P Monaco
Journal:  Genomics       Date:  2004-09       Impact factor: 5.736

7.  Further delineation of the Cohen syndrome; report on chorioretinal dystrophy, leukopenia and consanguinity.

Authors:  R Norio; C Raitta; E Lindahl
Journal:  Clin Genet       Date:  1984-01       Impact factor: 4.438

8.  Delineation of Cohen syndrome following a large-scale genotype-phenotype screen.

Authors:  Juha Kolehmainen; Robert Wilkinson; Anna-Elina Lehesjoki; Kate Chandler; Satu Kivitie-Kallio; Jill Clayton-Smith; Ann-Liz Träskelin; Laura Waris; Anne Saarinen; Jabbar Khan; Varda Gross-Tsur; Elias I Traboulsi; Mette Warburg; Jean-Pierre Fryns; Reijo Norio; Graeme C M Black; Forbes D C Manson
Journal:  Am J Hum Genet       Date:  2004-05-12       Impact factor: 11.025

9.  Cohen syndrome in the Ohio Amish.

Authors:  Marni J Falk; Heidi S Feiler; Derek E Neilson; Kathleen Maxwell; James V Lee; Samantha K Segall; Nathaniel H Robin; Kirk C Wilhelmsen; Ann-Liz Träskelin; Juha Kolehmainen; Anna-Elina Lehesjoki; Max Wiznitzer; Matthew L Warman
Journal:  Am J Med Genet A       Date:  2004-07-01       Impact factor: 2.802

10.  SOI1 encodes a novel, conserved protein that promotes TGN-endosomal cycling of Kex2p and other membrane proteins by modulating the function of two TGN localization signals.

Authors:  J H Brickner; R S Fuller
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

View more
  19 in total

1.  Cohen syndrome - a rare genetic cause of hypotonia in children.

Authors:  Magdalena Budisteanu; Diana Barca; Sorina Mihaela Chirieac; Sanda Magureanu
Journal:  Maedica (Buchar)       Date:  2010-01

2.  High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome.

Authors:  Veronica Parri; Eleni Katzaki; Vera Uliana; Francesca Scionti; Rossella Tita; Rosangela Artuso; Ilaria Longo; Renske Boschloo; Raymon Vijzelaar; Angelo Selicorni; Francesco Brancati; Bruno Dallapiccola; Leopoldo Zelante; Christian P Hamel; Pierre Sarda; Seema R Lalani; Rita Grasso; Sabrina Buoni; Joussef Hayek; Laurent Servais; Bert B A de Vries; Nelly Georgoudi; Sheena Nakou; Michael B Petersen; Francesca Mari; Alessandra Renieri; Francesca Ariani
Journal:  Eur J Hum Genet       Date:  2010-05-12       Impact factor: 4.246

3.  Vps13b is required for acrosome biogenesis through functions in Golgi dynamic and membrane trafficking.

Authors:  Romain Da Costa; Morgane Bordessoules; Magali Guilleman; Virginie Carmignac; Vincent Lhussiez; Hortense Courot; Amandine Bataille; Amandine Chlémaire; Céline Bruno; Patricia Fauque; Christel Thauvin; Laurence Faivre; Laurence Duplomb
Journal:  Cell Mol Life Sci       Date:  2019-06-19       Impact factor: 9.261

4.  Clinical and molecular characterization of Italian patients affected by Cohen syndrome.

Authors:  Eleni Katzaki; Chiara Pescucci; Vera Uliana; Filomena Tiziana Papa; Francesca Ariani; Ilaria Meloni; Manuela Priolo; Angelo Selicorni; Donatella Milani; Rita Fischetto; Maria Elena Celle; Rita Grasso; Bruno Dallapiccola; Francesco Brancati; Marta Bordignon; Romano Tenconi; Antonio Federico; Francesca Mari; Alessandra Renieri; Ilaria Longo
Journal:  J Hum Genet       Date:  2007-11-08       Impact factor: 3.172

5.  Cohen syndrome-associated protein COH1 physically and functionally interacts with the small GTPase RAB6 at the Golgi complex and directs neurite outgrowth.

Authors:  Wenke Seifert; Jirko Kühnisch; Tanja Maritzen; Stefanie Lommatzsch; Hans Christian Hennies; Sebastian Bachmann; Denise Horn; Volker Haucke
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

6.  Genomic insights into early-onset obesity.

Authors:  Hélène Choquet; David Meyre
Journal:  Genome Med       Date:  2010-06-23       Impact factor: 11.117

7.  Using whole-exome sequencing to identify inherited causes of autism.

Authors:  Timothy W Yu; Maria H Chahrour; Michael E Coulter; Sarn Jiralerspong; Kazuko Okamura-Ikeda; Bulent Ataman; Klaus Schmitz-Abe; David A Harmin; Mazhar Adli; Athar N Malik; Alissa M D'Gama; Elaine T Lim; Stephan J Sanders; Ganesh H Mochida; Jennifer N Partlow; Christine M Sunu; Jillian M Felie; Jacqueline Rodriguez; Ramzi H Nasir; Janice Ware; Robert M Joseph; R Sean Hill; Benjamin Y Kwan; Muna Al-Saffar; Nahit M Mukaddes; Asif Hashmi; Soher Balkhy; Generoso G Gascon; Fuki M Hisama; Elaine LeClair; Annapurna Poduri; Ozgur Oner; Samira Al-Saad; Sadika A Al-Awadi; Laila Bastaki; Tawfeg Ben-Omran; Ahmad S Teebi; Lihadh Al-Gazali; Valsamma Eapen; Christine R Stevens; Leonard Rappaport; Stacey B Gabriel; Kyriacos Markianos; Matthew W State; Michael E Greenberg; Hisaaki Taniguchi; Nancy E Braverman; Eric M Morrow; Christopher A Walsh
Journal:  Neuron       Date:  2013-01-23       Impact factor: 17.173

8.  Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians.

Authors:  F-Y Deng; L-J Zhao; Y-F Pei; B-Y Sha; X-G Liu; H Yan; L Wang; T-L Yang; R R Recker; C J Papasian; H-W Deng
Journal:  Osteoporos Int       Date:  2009-08-13       Impact factor: 4.507

9.  Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).

Authors:  Akihiro Abe; Yukiya Yamamoto; Akira Katsumi; Akinao Okamoto; Masutaka Tokuda; Yoko Inaguma; Kiyoko Yamamoto; Masamitsu Yanada; Tadaharu Kanie; Akihiro Tomita; Yoshiki Akatsuka; Masataka Okamoto; Toshiki Kameyama; Akila Mayeda; Nobuhiko Emi
Journal:  Int J Hematol       Date:  2017-12-20       Impact factor: 2.490

10.  Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects.

Authors:  Eunju Seong; Ryan Insolera; Marija Dulovic; Erik-Jan Kamsteeg; Joanne Trinh; Norbert Brüggemann; Erin Sandford; Sheng Li; Ayse Bilge Ozel; Jun Z Li; Tamison Jewett; Anneke J A Kievit; Alexander Münchau; Vikram Shakkottai; Christine Klein; Catherine A Collins; Katja Lohmann; Bart P van de Warrenburg; Margit Burmeister
Journal:  Ann Neurol       Date:  2018-06-30       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.